Posture Stability and Functional Activity Changes After Transcranial Photobiomodulation for Patients With Parkinson's Disease: A Randomized Controlled Trial

Al-Zaytoonah University of Jordan1 site in 1 country38 target enrollmentDecember 15, 2024

ConditionsParkinson Disease

Overview

Phase: N/A
Intervention: Not specified
Conditions: Parkinson Disease
Sponsor: Al-Zaytoonah University of Jordan
Enrollment: 38
Locations: 1
Primary Endpoint: posture stability
Status: Completed
Last Updated: last year

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

Parkinson's disease (PD) is the second most common neurodegenerative disorder after Alzheimer's disease. It is a progressive and disabling disease with significative impact on quality of life. Since it has no cure, available treatment is targeted to improve the symptoms due to a lack of dopamine in the central nervous system. The aim of the study was to see how transcranial photobiomodulation (tPBM) helped patients with Parkinson's disease.

Registry

clinicaltrials.gov

Start Date

December 15, 2024

End Date

April 3, 2025

Last Updated

last year

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

Al-Zaytoonah University of Jordan

Responsible Party

Principal Investigator

Hanan Hosny M Battesha

associate professor hanan hosny M Battesha

Al-Zaytoonah University of Jordan

Eligibility Criteria

Inclusion Criteria

•idiopathic PD,
•Hoehn \& Yahr stage I-IV,
•independent gait with or without technical assistance
•stable parkinsonian medication for at least a month before the study star.

Exclusion Criteria

•comorbidities that affect balance or walking,
•other neurological pathologies besides PD,
•chronic diseases not medically controlled and participation in another physiotherapy program or sport activity during the intervention period or in the month before starting the study

Outcomes

Primary Outcomes

posture stability

Time Frame: 8 weeks

The Biodex Balance System (Biodex Medical Systems Inc, USA) Will be used to assess the limit of stability (overall, forward and backward) pre- and post-treatment.